Developing Novel Drugs

higher stock market value. Using variation in the expansion of Medicare prescription drug coverage, we show that rms respond to a plausibly exogenous cash ow shock by developing more molecularly novel drug compounds, as opposed to more so-called \me-too" drugs. This pattern suggests that, on the margin, rms perceive novel drugs ................
................

In order to avoid copyright disputes, this page is only a partial summary.